NewslettersPancreatic Cell News Rintatolimod in Advanced Pancreatic Cancer Enhances Anti-Tumor Immunity through Dendritic Cell-Mediated T Cell Responses By Jamie Kang - March 28, 2024 0 Investigators studied the effect of TLR-3 activation through rintatolimod on the peripheral immune landscape of advanced PDAC patients. [Clinical Cancer Research] Abstract